These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4612875)

  • 1. Changes in plasma levels of FSH, LH and testosterone during anti-androgenic hormone therapy for patients with prostatic cancer.
    Shirai M; Matsuda S; Mitsukawa S; Nakamura M; Yonezawa K
    Tohoku J Exp Med; 1974 Oct; 114(2):145-58. PubMed ID: 4612875
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.
    Boyns AR; Cole EN; Phillips ME; Hillier SG; Cameron EH; Griffiths K; Shahmanesh M; Feneley RC; Hartog M
    Eur J Cancer (1965); 1974 Jul; 10(7):445-9. PubMed ID: 4376085
    [No Abstract]   [Full Text] [Related]  

  • 3. Luteinizing hormone, follicle stimulating hormone and testosterone in normal and impotent men following LHRH and HCG stimulation.
    Delitala G; Masala A; Alagna S; Lotti G
    Clin Endocrinol (Oxf); 1977 Jan; 6(1):11-15. PubMed ID: 321154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of testosterone, FSH and LH on plasma in patients with prostatic adenoma and carcinoma before and after different hormonal treatments].
    Garcia de la Peña E; Ramos F; Horcajada C; Cifuentes Delatte L; Vivanco F
    Rev Clin Esp; 1978 Jan; 148(1):19-23. PubMed ID: 76325
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hormonal therapy on plasma FSH, LH and testosterone levels in prostatic cancer].
    Shirai M; Matsuda S; Mitsukawa S; Nakamura M; Yonezawa K
    Nihon Hinyokika Gakkai Zasshi; 1975 Feb; 66(2):59-67. PubMed ID: 1168823
    [No Abstract]   [Full Text] [Related]  

  • 6. Supposed pituitary-production of human chorionic Gonadotropin induced by androgen deprivation therapy.
    Yoshimura K; Nakashima Y; Sugiyama K; Kohei N; Takizawa A
    Int Braz J Urol; 2019; 45(1):38-44. PubMed ID: 29757577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine changes after diethylstilbestrol therapy. Effects on prostatic neoplasm and pituitary-gonadal axis.
    Prout GR; Kliman B; Daly JJ; MacLaughlin RA; Griffin PP; Young HH
    Urology; 1976 Feb; 7(2):148-55. PubMed ID: 1246784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new male hypogonadism mutant rat (hgn/hgn): concentrations of testosterone (T), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) in the serum and the responsiveness of accessory sex organs to exogenous T, FSH, human chorionic gonadotropin, and luteinizing hormone-releasing hormone.
    Hakamata Y; Kikukawa K; Kamei T; Suzuki K; Taya K; Sasamoto S
    Biol Reprod; 1988 Jun; 38(5):1145-53. PubMed ID: 3136809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones].
    Weidner W; Krause W; Pust R; Engstfeld J; Rothauge CF
    Helv Chir Acta; 1978 Jul; 45(3):287-90. PubMed ID: 701064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
    Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
    Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the endocrine manifestations of hepatic cirrhosis.
    Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
    Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Male hormone--blood LH, FSH, and testosterone levels and LH-RH and HCG loading tests].
    Shimazaki J; Ito H
    Nihon Rinsho; 1979 Jun; Suppl():2595-9. PubMed ID: 385940
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study on cryptorchidism. Report 1. Changes in plasma levels of FSH, LH and testosterone in cryptorchidism with loading of luteinizing hormone-releasing hormone (author's transl)].
    Matsuda S
    Nihon Hinyokika Gakkai Zasshi; 1975 Aug; 66(8):462-6. PubMed ID: 531
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of cyproterone acetate on the plasma gonadotrophin response to gonadotrophin releasing hormone.
    Donald RA; Espiner EA; Cowles RJ; Fazackerley JE
    Acta Endocrinol (Copenh); 1976 Apr; 81(4):680-4. PubMed ID: 769466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dexamethasone on plasma concentrations of LH, FSH and testosterone in women with hirsutism.
    Böhm P; Cöllü H; Pitzel L; König A
    Endokrinologie; 1979; 73(3):301-6. PubMed ID: 499098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypothalamo-hypophyseal-gonadal axis in the Prader-Labhardt-Willi syndrome].
    Zappulla F; Salardi S; Tassinari D; Villa MP; Fréjaville E; Ventura D; Montanari P
    Minerva Pediatr; 1981 Mar; 33(5):201-4. PubMed ID: 6787402
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of short-term hyperprolactinemia on the endocrine reproductive system in male rabbits.
    Laborde NP; Odell WD
    Fertil Steril; 1984 Sep; 42(3):459-65. PubMed ID: 6432592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained impairment of pituitary and testicular function in prostatic cancer patients treated with a depot form of a GnRH agonist.
    Rolandi E; Franceschini R; Giberti C; Brancadoro T; Martorana G; Barreca T
    Horm Res; 1988; 30(1):22-5. PubMed ID: 2975631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary LH and FSH and testosterone secretion in infants with undescended testes.
    Job JC; Gendrel D; Safar A; Roger M; Chaussain JL
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):644-9. PubMed ID: 17259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
    Kobayashi T; Nishizawa K; Mitsumori K
    Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.